Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avik Shome

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Biochimica Et Biophysica Acta. General Subjects|June 26, 2020
Central administration of β-MSH reduces body weight in obese male Pomc<sup>tm1/tm1</sup> miceAvik Shome, Ailsa McGregor, Alana Cavadino, et al.
Biomedicines|July 29, 2023
Comprehensive Grading System for Experimental Autoimmune Uveitis in MiceAvik Shome, Odunayo O Mugisho, Rachael L Niederer, et al.
Drug Discovery Today|July 6, 2021
Blocking the inflammasome: A novel approach to treat uveitisAvik Shome, Odunayo O Mugisho, Rachael L Niederer, et al.
Animal Models and Experimental Medicine|March 29, 2025
The NLRP3 inflammasome pathway contributes to chronic inflammation in experimental autoimmune uveitisAvik Shome, Ilva D Rupenthal, Rachael L Niederer, et al.
Endocrinology|April 19, 2019
Chronic High-Fat Diet Exacerbates Sexually Dimorphic Pomctm1/tm1 Mouse ObesityKristina Hubbard, Avik Shome, Bo Sun, et al.
European Journal of Pharmacology|December 6, 2025
Inhibiting the NLRP3 inflammasome pathway: An effective way to treat chronic inflammation in experimental autoimmune uveitisAvik Shome, Odunayo O Mugisho, Priyanka Agarwal, et al.
International Journal of Molecular Sciences|January 5, 2021
Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic RetinopathyHeather Lyon, Avik Shome, Ilva D Rupenthal, et al.
Survey of Ophthalmology|May 4, 2026
Quantitative imaging for assessing uveitis activity: A comprehensive reviewAmin Nabavi, Mohammad Zarei, Avik Shome, et al.
Experimental Eye Research|December 7, 2020
Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathyHenry H Louie, Avik Shome, Charisse Yj Kuo, et al.
International Journal of Molecular Sciences|February 25, 2023
Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic RetinopathyOdunayo O Mugisho, Jyoti Aryal, Avik Shome, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Biochimica Et Biophysica Acta. General Subjects|June 26, 2020
Central administration of β-MSH reduces body weight in obese male Pomc<sup>tm1/tm1</sup> miceAvik Shome, Ailsa McGregor, Alana Cavadino, et al.
Biomedicines|July 29, 2023
Comprehensive Grading System for Experimental Autoimmune Uveitis in MiceAvik Shome, Odunayo O Mugisho, Rachael L Niederer, et al.
Drug Discovery Today|July 6, 2021
Blocking the inflammasome: A novel approach to treat uveitisAvik Shome, Odunayo O Mugisho, Rachael L Niederer, et al.
Animal Models and Experimental Medicine|March 29, 2025
The NLRP3 inflammasome pathway contributes to chronic inflammation in experimental autoimmune uveitisAvik Shome, Ilva D Rupenthal, Rachael L Niederer, et al.
Endocrinology|April 19, 2019
Chronic High-Fat Diet Exacerbates Sexually Dimorphic Pomctm1/tm1 Mouse ObesityKristina Hubbard, Avik Shome, Bo Sun, et al.
European Journal of Pharmacology|December 6, 2025
Inhibiting the NLRP3 inflammasome pathway: An effective way to treat chronic inflammation in experimental autoimmune uveitisAvik Shome, Odunayo O Mugisho, Priyanka Agarwal, et al.
International Journal of Molecular Sciences|January 5, 2021
Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic RetinopathyHeather Lyon, Avik Shome, Ilva D Rupenthal, et al.
Survey of Ophthalmology|May 4, 2026
Quantitative imaging for assessing uveitis activity: A comprehensive reviewAmin Nabavi, Mohammad Zarei, Avik Shome, et al.
Experimental Eye Research|December 7, 2020
Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathyHenry H Louie, Avik Shome, Charisse Yj Kuo, et al.
International Journal of Molecular Sciences|February 25, 2023
Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic RetinopathyOdunayo O Mugisho, Jyoti Aryal, Avik Shome, et al.
Pageof 2